Written Question·Department of Health and Social Care·UIN 15627

Metabolic Dysfunction-associated Steatohepatitis

Tabled: 2 July 2026

Answered: 10 July 2026

Question

Lorraine Beavers

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of retiring the OHID Liver Disease Fingertips Profiles on the UK's ability to monitor steatotic liver disease indicators and meet the World Healt

Answer

Mrs Sharon Hodgson

The Office for Health Improvement and Disparities (OHID) continues to monitor a wide range of indicators relating to steatotic liver disease, an umbrella term that includes a range of conditions where fat accumulates in liver cells causing dysfunction. In...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 15627) →